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A case of hemocholecyst associated with hemobilia 
following radiofrequency ablation therapy for 
hepatocellular carcinoma
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Min Kyu Jung, Chang Min Cho, Won Young Tak, and Young Oh Kweon
Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea
Radiofrequency ablation (RFA) is performed as an alternative to surgical resection for primary or secondary liver malignancies. 
Although RFA can be performed safely in most patients, early and late complications related to mechanical or thermal damage 
occur in 8-9.5% cases. Hemocholecyst, which refers to hemorrhage of the gallbladder, has been reported with primary 
gallbladder disease or as a secondary event associated with hemobilia. Hemobilia, defined as hemorrhage in the biliary tract and 
most commonly associated with accidental or iatrogenic trauma, is a rare complication of RFA. Here we report a case of 
hemocholecyst associated with hemobilia after RFA for hepatocellular carcinoma that was successfully managed by 
laparoscopic cholecystectomy. (Korean J Hepatol 2011;17:148-151)
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INTRODUCTION
Hepatocellular carcinoma (HCC) is the most common 
primary malignant liver tumor. Although surgical resection is the 
best curative treatment option,
1,2 there are several obstacles that 
limit surgical resection such as tumor number, location, hepatic 
reserve, and patient performance status.
3 Therefore, alternative 
techniques such as percutaneous ethanol injection (PEI), microwave 
therapy, radiofrequency ablation (RFA), and transcatheter 
arterial chemoembolization (TACE) have been practiced for the 
treatment of HCC.
4-6 
RFA is an effective loco-regional treatment for hepatocellular 
carcinoma that was first introduced  in 1996.
7 As a minimally 
invasive procedure, RFA is considered as a relatively simple and 
safe modality for treatment of HCC. However RFA may cause 
early and late complications related to mechanical and thermal 
damage. Post-RFA complications such as liver abscess, tumor 
seeding, pleural effusion, pneumothorax, gastrointestinal perforation, 
intraperitoneal bleeding, and skin burn have been reported from 
5.2% to 9.5% in literature.
8-10
Hemobilia is defined as hemorrhage from the biliary tree. 
Melena and upper abdominal pain are common symptoms of 
hemobilia. The causes of hemobilia are known as trauma, 
infection, tumor, inflammation, and gallstones. Hemobilia has 
been reported as a rare biliary complication after percutaneous 
hepatic intervention.
11 Hemocholecyst secondary to hemobilia is 
also a rare sequelae of hemobilia.
As we experienced hemobilia accompanied with hemocholecyst 
after RFA for treatment of HCC, we report clinical course and 
management of the present case.
CASE REPORT
A 69-year-old man visited the emergency room due to right 
upper quadrant abdominal pain for two days. He had a medical 
history of hypertension, cerebral infarction, and liver cirrhosis Keun Young Shin, et al. Hemobilia and hemocholecyst following radiofrequency ablation therapy in HCC  149
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Figure 1. (A) Computed tomography (CT) scan showing a small enhanced nodule (arrow) in segment 8. (B) The same lesion after 
radiofrequency ablation (RFA) therapy.
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Figure 2. A nonenhanced mass-like lesion (arrow), considered as hematoma, was seen in gallbladder after RFA. The hematoma was 
measured as 65.8 HU (Hounsfield units) in precontrast scan (A) and as 66.0 HU in portal-phase scan (B). Abdominal ultrasonography 
revealed a heterogeneous echogenic mass in the gallbladder (C). Endoscopic retrograde cholangiopancreatography showed a gallbladder 
with a localized filling defect (arrow) (D).150  The Korean Journal of Hepatology Vol. 17. No. 2, June 2011
Figure 4. Histological findings of the gallbladder wall showing 
hemorrhage and diffuse infiltration of inflammatory cells (hema-
toxylin and eosin stain, ×40).
Figure 3. Follow-up CT scan showing that the mass-like lesion 
decreased in size.
secondary to chronic hepatitis B virus infection. Two weeks ago, 
the patient was treated with RFA for 14 mm sized HCC in 
segment 8 (Fig. 1A, B). Physical examination and laboratory 
findings were within normal range when RFA was performed. 
Percutaneous RFA was performed under local anesthesia using 
cool-tip electrode with a 3-cm exposed tip (ACT2030, Valleylab, 
Boulder, Colorado, U.S.A) according to manufacture’s manual. 
Multiple overlapping ablations were applied for 2 cycles with 12 
minutes each cycle. Patient was discharged from hospital 24 
hours after RFA without any immediate complication. The 
patient was doing well after discharge. Ten days after discharge, 
patient had nausea and right upper abdominal discomfort. The 
patient felt severe progressive right upper abdominal pain 
associated with fever. Physical examination showed tenderness 
at right upper abdomen with positive Murphy’s sign. Laboratory 
finding showed increased serum levels of alanine transaminase 
(242 IU/L from 24 IU/L), total bilirubin (3.6 mg/dL from 0.4 
mg/dL), and decreased hemoglobin level (12.1 g/dL from 15.1 
g/dL). Acute infection was suggested by leukocyte count 
(20,180/mm
3), C-reactive protein (14.2 mg/dL). Abdominal 
computed tomogram (CT) showed gallbladder (GB) filled with 
high density material, considered as hematoma (Fig. 2A, B). 
Abdominal ultrasonography revealed heterogenous echogenic 
mass in GB (Fig. 2C). Endoscopic retrograde cholangio- 
pancreatography (ERCP) showed an irregular shaped filling 
defect in GB with normal cholangiogram (Fig. 2D). Abdominal 
pain gradually decreased with antibiotic therapy after endoscopic 
sphincterectomy to decompress the bile duct. The follow up CT 
scan three days after ERCP showed a decreased but remnant 
mass-like lesion within GB (Fig. 3). Due to persistent pain, 
laparoscopic cholecystectomy was performed. There were blood 
clots in GB wall and shows no source of bleeding. The pathologic 
examination showed hemorrhage and diffuse infiltration of 
inflammatory cells at GB wall without primary GB pathology 
(Fig. 4). After cholecystectomy, Patient’s symptom subsided and 
laboratory finding improved. The patient was discharged five 
days after cholecystectomy without any complication.
DISCUSSION
Hemobilia involving the GB can present with signs and 
symptoms of upper gastrointestinal bleeding and eventually lead 
to GB rupture and hemoperitoneum, when cystic duct is 
obstructed by blood clots.
12,13 The mechanism of hemobilia after 
RFA is mainly due to direct traumatic injury to biliary and 
vascular structures during electrode advancement and thermal 
injury may also contribute to bile duct and vascular damage.
14 
Hemobilia related to RFA has been reported ranging from 0.02% 
to 0.25%.
12-14
The term “hemocholecyst”, introduced in 1961, refers to 
describe hemorrhage of GB. Originally, this term applies only to 
atraumatic bleeding confined to the GB.
15,16 However, it might be 
very difficult to differentiate hemocholecyst from hemobilia in 
clinical practice. Hemocholecyst can cause hemobilia, or vice 
versa, hemobilia may result in hemocholecyst.
17,18 Causes of 
primary hemocholecyst are limited including GB cancer, 
cholelithiasis, vascular disorders, and the presence of heterotopic 
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can be resulted from iatrogenic trauma, such as liver biopsy and 
RFA.
12,13,16 The diagnosis of hemocholecyst is difficult. The 
sonographic appearance of blood clots within the GB appears as 
clumps of echogenic material. CT scan can show high density 
mass-like lesion in distended GB and high density mass.
19 ERCP 
can identify evidence of bleeding at duodenal ampullar in only 
30% of patients. In the present case, we identified high 
attenuating mass like lesion in GB through sonography and 
abdominal CT scan, which showed hematoma density about 60 
Hounsfield number in CT scan. ERCP failed to show evidence of 
bleeding in biliary system in present case, which is mainly due to 
time delay of 2 weeks between ERCP and RFA. Direct GB injury 
from RFA might be an another etiology of hemocholecyst, but, 
considering the fact that the ablation site is not close from the 
GB, We presumed that hemocholecyst is associated with 
hemobilia after RFA. Although definite hemobilia could not be 
identified, no histologic evidence of primary GB disease causing 
hemorrhage made it diagnosed as hemocholecyst associated with 
hemobilia
It is difficult to provide an algorithm for management of 
hemocholecyst associated with hemobilia. There are various 
treatment options proposed. Once the clot in the GB begins to 
organize, it is very unlikely to dissolve. Therefore in most cases, 
open or laparoscopic cholecystectomy should be performed.
20 
Laparoscopic cholecystectomy was performed in present case 
due to persistent pain and the patient successfully recovered.
We assume the thermal injury during RFA caused hemobilia 
subacutely which eventually resulted in hemocholecyst. We 
diagnosed the hemocholecyst by abdominal ultrasound and CT 
scan. We performed ERCP to decompress biliary tract by 
endoscopic sphincterotomy. Eventually the patient was 
successfully managed by laparoscopic cholecystectomy. 
In conclusion, although hemocholecyst associated with 
hemobilia is a very rare complication of RFA, we should suspect 
possibility of this complication in patients presenting with 
continued abdominal pain and decrease in hemoglobin level 
without obvious cause. Early recognition and management is 
crucial not to miss the chance for the opportune treatment. 
Prompt surgical management should be considered when 
medical therapy fails to improve clinical course.
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